Wave Life Sciences (WVE) Assets Average (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Assets Average for 11 consecutive years, with $439.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Assets Average rose 23.8% year-over-year to $439.9 million, compared with a TTM value of $439.9 million through Dec 2025, up 23.8%, and an annual FY2025 reading of $495.4 million, up 57.97% over the prior year.
- Assets Average was $439.9 million for Q4 2025 at Wave Life Sciences, up from $246.9 million in the prior quarter.
- Across five years, Assets Average topped out at $439.9 million in Q4 2025 and bottomed at $163.9 million in Q4 2022.
- Average Assets Average over 5 years is $246.7 million, with a median of $231.0 million recorded in 2021.
- The sharpest move saw Assets Average plummeted 30.85% in 2021, then surged 49.67% in 2024.
- Year by year, Assets Average stood at $203.8 million in 2021, then decreased by 19.54% to $163.9 million in 2022, then skyrocketed by 44.82% to $237.4 million in 2023, then soared by 49.67% to $355.4 million in 2024, then grew by 23.8% to $439.9 million in 2025.
- Business Quant data shows Assets Average for WVE at $439.9 million in Q4 2025, $246.9 million in Q3 2025, and $270.3 million in Q2 2025.